Physical Activity for a Long and Healthy Life
- Conditions
- Diabetes Mellitus, Type 2Insulin ResistanceOverweight
- Interventions
- Behavioral: Exercise
- Registration Number
- NCT01430143
- Lead Sponsor
- University of Copenhagen
- Brief Summary
The aim of the study is to 1) delineate the molecular mechanisms behind the large variation in insulin sensitivity among apparently healthy subjects and to 2) establish the dose-response relationship between physical training and a) metabolic health, b) appetite and c) cultural health.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 64
- Healthy according to interview
- Caucasian
- Sedentary, Vo2max < 45 ml/kg/min
- BMI 25-30 kg/m2
- Fat percentage 25% <
- Weight stable (+/- 2 kg within past 6 months)
- First degree relatives with type 2 diabetes
- Hemoglobin concentration < 8 mmol/l
- Fasting plasma glucose 6.1 mmol/l <
- Blood pressure 140/90 mmHg <
- Regular intake of medicine
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 600 kcal/day Exercise Exercise combusting 600 kcal/day, 7 days/week for 12 weeks. 300 kcal/day Exercise Exercise combusting 300 kcal/day, 7 days/week for 12 weeks.
- Primary Outcome Measures
Name Time Method Change from baseline in insulin sensitivity at 12 weeks At baseline and 12 weeks As measured by a hyperinsulinemic, isoglycemic clamp combined with skeletal muscle and adipose tissue biopsies as well as low-dose PET/CT.
- Secondary Outcome Measures
Name Time Method Change from baseline in appetite at 12 weeks At baseline and 12 weeks As measured by food records, controlled diets, meal tests and appetite hormones
Motivational factors for exercise During and for up to 1½ year after the intervention Ethnographic field work
Diameter of t-tubuli in skeletal muscle At baseline As measured in skeletal muscle biopsies by electron and confocal microscopy
Change from baseline in body composition af 2, 6 and 12 weeks At baseline, 2, 6 and 12 weeks As measured by DEXA- and MRI-scanning.
Trial Locations
- Locations (1)
Department of Biomedical Sciences, The University of Copenhagen
🇩🇰Copenhagen, Denmark